Why the study?
Does early renin-angiotensin system intervention delay end-stage renal disease more than late intervention in patients with type 2 diabetes and proteinuric DKD?
Does early renin-angiotensin system intervention delay end-stage renal disease more than late intervention in patients with type 2 diabetes and proteinuric DKD?
Answers are grounded in this paper and cite their sources.
Early initiation of RAS inhibitors in proteinuric diabetic kidney disease provides greater benefit in delaying ESRD compared to late initiation.
RAS intervention early in the course of proteinuric DKD is more beneficial than late intervention in delaying ESRD.
No takes yet. Share an insight, caveat, or question.
Schievink et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: